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498 Stapled coronary anastomosis with minimal intraluminal artifact: The S2
Anastomotic System in the off-pump porcine model
Willem J. L. Suyker, MD, Marc P. Buijsrogge, MD, PhD, Paul T. W. Suyker, MSc, MBA,
Cees W. J. Verlaan, Cornelius Borst, MD, PhD, and Paul F. Gru¨ndeman, MD, PhD,
Utrecht and Amsterdam, The Netherlands
A novel anastomotic device enabled high-quality, reproducible, and fast (3 minutes)
construction of internal thoracic to left anterior descending coronary anastomosis on the porcine
beating heart with excellent graft patency (FitzGibbon A) and healing characteristics after 5
weeks. This device may ultimately enable totally endoscopic multivessel coronary bypass
grafting.
504 Robotic totally endoscopic coronary artery bypass: Program development
and learning curve issues
J. Bonatti, T. Schachner, O. Bernecker, O. Chevtchik, N. Bonaros, H. Ott, G. Friedrich,
F. Weidinger, and G. Laufer, Innsbruck, Austria
A totally endoscopic coronary artery bypass grafting program using robotic techniques was
introduced over a period of 19 months using a stepwise and modular approach. Significant
learning curves were noted. According to clinical outcome of the series, safe introduction of the
program can be stated.
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511 Ventral cardiac denervation reduces the incidence of atrial fibrillation after
coronary artery bypass grafting Œ
Joa˜o Melo, MD, PhD, Peter Voigt, MD, Bingur Sonmez, MD, Manuel Ferreira, MD,
Miguel Abecasis, MD, Maria Rebocho, MD, Ana Timo´teo, MD, Carlos Aguiar, MD, Selim
Tansal, MD, Harun Arbatli, MD, and Robert Dion, MD, Carnaxide, Portugal, Istanbul, Turkey,
and Leiden, The Netherlands
We have used ventral cardiac denervation to reduce the incidence of atrial fibrillation after
coronary artery bypass grafting and achieved a significant reduction from 27% to 7%. Patients
younger than 70 years of age are more likely to benefit more from this procedure than older
patients.
517 Cardiac denervation after clinical transmyocardial laser revascularization:
Short-term and long-term iodine 123–labeled meta-iodobenzylguanide
scintigraphic evidence
Johan F. Beek, MD, PhD, Jos A. P. van der Sloot, MD, PhD, Menno Huikeshoven, PhD,
Hein J. Verberne, MD, Berthe L. F. van Eck-Smit, MD, PhD, Jan van der Meulen, MD,
Jan G. P. Tijssen, PhD, Martin J. C. van Gemert, PhD, and Raymond Tukkie, MD, PhD,
Amsterdam, The Netherlands
After Holmium:YAG or excimer transmyocardial laser revascularization (TMLR), angina was
reduced by 2 or more classes, quality of life improved significantly, results of perfusion
scintigraphy did not change, and iodine 123–labeled meta-iodobenzylguanide SPECT
scintigraphy demonstrated myocardial denervation (P  .00005) in all 8 patients. In conclusion,
TMLR-induced clinical improvement can be explained by destruction of nociceptors or cardiac
neural pathways.
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